ElevatION: CRC-101: A Phase Ib Study of PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer
Phase of Trial: Phase I
Latest Information Update: 19 Jun 2019
Price : $35 *
At a glance
- Drugs Spartalizumab (Primary) ; Bevacizumab; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ElevatION
- Sponsors Novartis Pharmaceuticals
- 09 Jan 2019 Status changed to discontinued due to company decision.
- 19 Feb 2018 Status changed from active, no longer recruiting to recruiting.
- 19 Feb 2018 Planned End Date changed from 7 Jan 2021 to 4 Jun 2019.